-
EP3345654
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3345654
| EP3345654 - PHARMACEUTICAL COMPOSITION CONTAINING CAMPTOTHECIN POLYMER DERIVATIVE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 14.06.2024 Database last updated on 24.08.2024 | |
| Former | Examination is in progress Status updated on 14.01.2022 | ||
| Former | Request for examination was made Status updated on 08.06.2018 | ||
| Former | The international publication has been made Status updated on 11.03.2017 | Most recent event Tooltip | 14.06.2024 | Application deemed to be withdrawn | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states Nippon Kayaku Kabushiki Kaisha 1-1, Marunouchi 2-chome Chiyoda-ku Tokyo 100-0005 / JP | [2018/28] | Inventor(s) | 01 /
AOKI Shin c/o NIPPON KAYAKU KABUSHIKI KAISHA Pharmaceuticals Research Laboratories 31-12 Shimo 3-chome Kita-ku Tokyo 115-8588 / JP | 02 /
FUJITA Shinya c/o NIPPON KAYAKU KABUSHIKI KAISHA Pharmaceuticals Research Laboratories 31-12 Shimo 3-chome Kita-ku Tokyo 115-8588 / JP | [2018/28] | Representative(s) | Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | [2018/28] | Application number, filing date | 16841639.4 | 25.08.2016 | [2018/28] | WO2016JP74762 | Priority number, date | JP20150173755 | 03.09.2015 Original published format: JP 2015173755 | [2018/28] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017038607 | Date: | 09.03.2017 | Language: | JA | [2017/10] | Type: | A1 Application with search report | No.: | EP3345654 | Date: | 11.07.2018 | Language: | EN | [2018/28] | Search report(s) | International search report - published on: | JP | 09.03.2017 | (Supplementary) European search report - dispatched on: | EP | 08.04.2019 | Classification | IPC: | A61K47/64, A61K47/60, A61P35/00 | [2019/19] | CPC: |
A61K47/60 (EP,KR,RU,US);
A61K9/19 (EP,KR,RU,US);
A61K31/4745 (EP,KR,RU,US);
A61K31/787 (RU);
A61K47/26 (EP,KR,RU,US);
A61K47/50 (RU);
A61K47/542 (US);
A61K47/645 (EP,RU,US);
A61K47/6935 (KR);
|
| Former IPC [2018/28] | A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/28] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT EINEM CAMPTOTHECINPOLYMERDERIVAT | [2018/28] | English: | PHARMACEUTICAL COMPOSITION CONTAINING CAMPTOTHECIN POLYMER DERIVATIVE | [2018/28] | French: | COMPOSITION PHARMACEUTIQUE À TENEUR EN DÉRIVÉ DE POLYMÈRE DE CAMPTOTHÉCINE | [2018/28] | Entry into regional phase | 22.02.2018 | Translation filed | 22.02.2018 | National basic fee paid | 22.02.2018 | Search fee paid | 22.02.2018 | Designation fee(s) paid | 22.02.2018 | Examination fee paid | Examination procedure | 22.02.2018 | Examination requested [2018/28] | 22.02.2018 | Date on which the examining division has become responsible | 08.10.2019 | Amendment by applicant (claims and/or description) | 18.01.2022 | Despatch of a communication from the examining division (Time limit: M04) | 27.05.2022 | Reply to a communication from the examining division | 01.03.2024 | Application deemed to be withdrawn, date of legal effect [2024/29] | 22.03.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2024/29] | Fees paid | Renewal fee | 29.08.2018 | Renewal fee patent year 03 | 27.08.2019 | Renewal fee patent year 04 | 10.08.2020 | Renewal fee patent year 05 | 19.08.2021 | Renewal fee patent year 06 | 12.08.2022 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 31.08.2023 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]EP3238730 (NIPPON KAYAKU KK [JP]) [E] 1-7 * examples 2,8,9 * * claim - *; | [I]WO2015125641 (NIPPON KAYAKU KK [JP]) [I] 1-5 * example 1 * | [I] - KOIZUMI FUMIAKI ET AL, "Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors", CANCER RESEARCH, PROCEEDINGS: AACR ANNUAL MEETING 2014; APRIL 5-9, 2014; SAN DIEGO, CA, (20061015), vol. 66, no. 20, doi:10.1158/0008-5472.CAN-06-1605, ISSN 0008-5472, pages 10048 - 10056, XP002578597 [I] 1-7 * abstract * * page 10050, column l, paragraph Results - page 10052, column l * DOI: http://dx.doi.org/10.1158/0008-5472.CAN-06-1605 | [X] - JIAN GONG ET AL, "Polymeric micelles drug delivery system in oncology", JOURNAL OF CONTROLLED RELEASE, vol. 159, no. 3, doi:10.1016/J.JCONREL.2011.12.012, ISSN 0168-3659, (20111206), pages 312 - 323, (20120121), XP028482923 [X] 1-7 * abstract * * page 316, column r, paragraph NL012 - page 317, column r * DOI: http://dx.doi.org/10.1016/j.jconrel.2011.12.012 | [X] - YASUHIRO MATSUMURA ED - KWON ICK CHAN ET AL, "Preclinical and clinical studies of NK012, an SN-38-incorporating polymeric micelles, which is designed based on EPR effect", ADVANCED DRUG DELIVERY REVIEWS, vol. 63, no. 3, doi:10.1016/J.ADDR.2010.05.008, ISSN 0169-409X, (20100521), pages 184 - 192, (20100531), XP028158145 [X] 1-7 * abstract * * page 185 * DOI: http://dx.doi.org/10.1016/j.addr.2010.05.008 | [X] - MATSUMURA Y, "Polymeric micellar delivery systems in oncology", JAPANESE JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 12, doi:10.1093/JJCO/HYN116, ISSN 0368-2811, (20081201), pages 793 - 802, (20081106), XP008102691 [X] 1-7 * abstract * * page 798 - page 800 * DOI: http://dx.doi.org/10.1093/jjco/hyn116 | [X] - MATSUMURA ET AL, "Poly (amino acid) micelle nanocarriers in preclinical and clinical studies", ADVANCED DRUG DELIVERY REVIEWS, vol. 60, no. 8, doi:10.1016/J.ADDR.2007.11.010, ISSN 0169-409X, (20080522), pages 899 - 914, (20080209), XP022624678 [X] 1-5 * abstract * * page 907 - page 908 * DOI: http://dx.doi.org/10.1016/j.addr.2007.11.010 | [X] - BALA VASKOR ET AL, "Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38", JOURNAL OF CONTROLLED RELEASE, (20131128), vol. 172, no. 1, doi:10.1016/J.JCONREL.2013.07.022, ISSN 0168-3659, pages 48 - 61, XP028772906 [X] 1-5 * abstract * * page 55, column r - page 56, column l; figure -; table - * DOI: http://dx.doi.org/10.1016/j.jconrel.2013.07.022 | International search | [X]WO2011049042 (NIPPON KAYAKU KK [JP], et al) [X] 1-7 * , claim 7; paragraphs [0004] to [0005], [0026] to [0029], [0037]; experimental examples & US 2012/0231053 A1 claim 7; paragraphs [0004] to [0005], [0056] to [0059], [0067]; Test examples & EP 2491951 A1 *; | [A]WO2004039869 (NIPPON KAYAKU KK [JP], et al) [A] 1-7 * , claims; examples & US 2006/0067910 A1 & EP 1580216 A1 & KR 10-2005-0070103 A & CN 1708540 A & RU 2005116309 A *; | [A]WO0205855 (DAIICHI SEIYAKU CO [JP], et al) [A] 1-7 * , claims; examples & US 2003/0148931 A1 & EP 1308171 A1 & CA 2415922 A & CN 1556712 A & RU 2003100532 A *; | [A]JP2005523329 (Tanabe Seiyaku Co., Ltd.) [A] 1-7 * , claims; examples & US 2005/0215485 A1 & WO 2003/086471 A2 & EP 1501549 A2 & CN 1646172 A & KR 10-2005-0000516 A & RU 2004133349 A * |